Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mycogen was a pioneering agricultural biotechnology company that specialized in the development of genetically modified crops and biopesticides. The company is best known for its innovative use of Bacillus thuringiensis (Bt) technology to engineer plants with internal resistance to insect pests, significantly reducing the need for external chemical sprays. Founded in 1982, Mycogen was one of the first firms to successfully commercialize transgenic traits in major crops such as corn, soybeans, and cotton. In addition to its trait research, the company operated a robust seed business, providing high-quality hybrids to farmers globally. Following a series of strategic investments, Mycogen was fully acquired by Dow AgroSciences in 1998 and its technologies are now part of Corteva Agriscience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mycogen Plant Sciences.